DRUG SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Bright Minds Biosciences

The Quick Take
Investors who lost money when DRUG shares sold off on the FDA's partial clinical hold for the planned Phase 2 BMB-101 epilepsy trial may have the right to seek recovery, even if they have already sold. NEW YORK, Nov. 3, 2026 /PRNewswire/ -- Shareholders of Bright Minds Biosciences...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Local
Massachusetts cannabis repeal is state’s most expensive ballot question in midterm elections
While there are no marijuana legalization ballot initiatives in the 2026 midterm elections, cannabis is still the costliest campaign question in Massachusetts,…
Business
APTIM Appoints Chuck Prow as Chief Executive Officer
BATON ROUGE, La., Nov. 3, 2026 /PRNewswire/ -- APTIM ("APTIM" or the "Company"), a leading environmental and resilience consulting firm with a long history of…
Local
MSRs trade at richest levels in decades as lenders, funds pile in
From Rate’s full retention stance to UWM’s bulk sale, strategies diverge
Business
Transfer Online Partners with OnchainTA, a Digital Transfer Agent, to Expand Tokenized Securities Services
The partnership establishes a framework for OnchainTA to provide tokenized securities capabilities to Transfer Online FULLERTON, Calif., Nov. 3, 2026…
